Skip to main content
. Author manuscript; available in PMC: 2015 Jan 14.
Published in final edited form as: Circulation. 2013 Oct 25;129(2):211–223. doi: 10.1161/CIRCULATIONAHA.113.001790

Table 3.

Six Lesions (Five Patients) with Cobalt-Chromium Everolimus-Eluting Stent Fracture

Case Age (yrs) Sex Vessel Stent type Stent length (mm) Indication of stenting Lesion calcification Duration of implant (days) Cause of death Stent outcome Number of fracture site (non-linear link/crown) Fracture grade
1 55 M RCA (prox) Xience V x2 + Taxus Ex x1 30 Stable CAD Severe 180 SRD (LST) LST at non-FS 2 (2/0) II
2 56 M LAD (prox) Xience V x1 + ML Vision x2 45 Stable CAD None 80 NCD (ARDS, vasculitis) Restenosis at non-FS 1 (1/0) I
3 51 M LOM (dist) Xience V x1 28 Stable CAD Mild 101 SRD (restenosis with diffuse CAD) Restenosis at FS 9 (9/0) V
4 82 M SVG (prox) Xience V x1 18 ACS Mild 360 NSRCD (diffuse CAD) Patent 1 (1/0) I
5* 70 F LM-LCX (prox) Xience V x2 28 ACS Severe 167 SRD (restenosis) Restenosis at FS 4 (1/3) III
70 F RCA (dist) Xience V x1 12 ACS Severe 167 SRD (restenosis) Restenosis at FS 3 (2/1) III
*

Previously published case (Foerst JR, et al. JACC. Cardiovascular Interventions 2012;5: 239–242).

ARDS=acute respiratory distress syndrome; Ex=Express; FS=fracture site; LOM=left obtuse marginal branch; LST=late stent thrombosis; ML=Multi-Link, NCD=noncardiac death; NSRCD=nonstent-related cardiac death; SRD=stent-related death; SVG=saphenous vein graft. Other abbreviations as in Table 1.